10 July 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the EU Pharmaceutical Strategy Roadmap

BEAM welcome the European Commission's ambition to support innovation in its upcoming Pharmaceutical Strategy. In our latest paper , we…

27 August 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the AMR Action Fund

The COVID-19 pandemic has stressed how drug and vaccine development requires time and resources. Whilst we welcome the launch of…

28 August 2020 - BEAM Alliance

BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics

18 November 2020 - Event

XIV European Patients’ Rights Day 2020 – Public and private sector challenges to address the “the Silent Tsunami”

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

17 November 2020 - Event

Fixing the antibiotic innovation pipeline; Online discussion hosted by the MEP Interest Group on AMR

The current antibiotic innovation pipeline is broken. The last antibiotic class that was successfully introduced as a treatment was discovered…

19 November 2020 - Event

XIV European Patients’ Rights Day 2020 – Towards an AMR citizens’ alliance

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

BEAM News
Member News
Events

Latest news of BEAM Alliance

18 November 2020 - BEAM Alliance

2020 Antimicrobial Resistance campaign: How to change the fight against AMR?

The BEAM Alliance recently worked with Global Cause on the 2020 Antimicrobial Resistance campaign.

09 November 2020 - BEAM Alliance

Antibiorésistance : Anticiper une nouvelle crise sanitaire

Florence Séjourné, présidente de BEAM Alliance : « Il faut anticiper les investissements en R&D dès maintenant pour avoir un…

28 August 2020 - BEAM Alliance

BEAM Alliance and global partners call for urgent action on new reimbursement models for life-saving antibiotics

27 August 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the AMR Action Fund

The COVID-19 pandemic has stressed how drug and vaccine development requires time and resources. Whilst we welcome the launch of…

10 July 2020 - BEAM Alliance

BEAM Alliance – Reflection paper on the EU Pharmaceutical Strategy Roadmap

BEAM welcome the European Commission's ambition to support innovation in its upcoming Pharmaceutical Strategy. In our latest paper , we…

02 April 2020 - BEAM Alliance

Request for Proposals (RFP) for an Agreement for Performance of Work (APW) to develop an online e-learning course on antimicrobial stewardship

To support the Antimicrobial Stewardship and Awareness (ASA) Unit in the Global Coordination and Partnership on Antimicrobial Resistance (GCP) department…

page 1/4

Tweets by alliancebeam

View twitter feed

Latest news of BEAM Members

26 November 2020 - MaaT Pharma

MaaT Pharma to Provide Data Update for Lead Microbiome Biotherapeutic in Oral Presentation at 62nd American Society of Hematology (ASH) Annual Meeting

MaaT Pharma, a clinical stage company, has established the most complete approach to restoring patient-microbiome symbiosis to improve survival outcomes…

24 November 2020 - Polyphor Ltd

Polyphor receives award of up to USD 3.3 million from Cystic Fibrosis Foundation to support clinical development of inhaled antibiotic murepavadin

Polyphor's inhaled murepavadin is currently being developed as a precision antibiotic specifically targeting chronic Pseudomonas aeruginosa, for the treatment of…

24 November 2020 - Juvabis AG

Juvabis AG is proud to announce positive Phase 1 results of EBL-1003 in the Innovative Medicines Initiative (IMI) ENABLE Consortium.

EBL-1003 is a crystalline free base of the aminoglycoside apramycin designed to treat Gramnegative bacterial infections. EBL-1003 for infusion has…

23 November 2020 - Nosopharm

Nosopharm lève 1.6 million contre la résistance aux antibiotiques

Nosopharm is an innovative biotechnology company specialized in exploring untapped microbial biodiversity in order to discover new drugs to fight…

19 November 2020 - DEINOVE

DEINOVE signs an Evaluation and Technology Development License with DSM

DEINOVE has several development programs underway, including the antibiotic candidate DNV3837, in a Phase II clinical trial in severe gastrointestinal…

19 November 2020 - GARDP Foundation

GARDP: Launch of the new REVIVE Antimicrobial Encyclopaedia

The Global Antibiotic Research and Development Partnership (GARDP) is a not-for-profit organization developing new treatments for drug-resistant infections that pose…

page 1/24

Events

11 January 2021

Biotech Showcase™ Digital 2021

Biotech Showcase™ Digital is an investor and networking conference devoted to providing private and small- and mid-cap biotechnology companies an…

20 November 2020

REVIVE Webinar: Saving childrens’ lives – treating neonatal sepsis

The webinar, organized in collaboration with WHO, is being held on the occasion of Universal Children’s Day and during World…

19 November 2020

XIV European Patients’ Rights Day 2020 – Towards an AMR citizens’ alliance

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

18 November 2020

XIV European Patients’ Rights Day 2020 – Public and private sector challenges to address the “the Silent Tsunami”

The XIV European Patients’ Rights Day (EPRD) will be celebrated by Active Citizenship Network (ACN) with a virtual multi-stakeholder conference which, this year, focuses…

17 November 2020

REVIVE Webinar: Discovery of new antibacterials using artificial intelligence (computational chemoinformatics)

In this webinar, the speakers will give an overview of their work on the discovery of antibiotics through the use…

17 November 2020

Fixing the antibiotic innovation pipeline; Online discussion hosted by the MEP Interest Group on AMR

The current antibiotic innovation pipeline is broken. The last antibiotic class that was successfully introduced as a treatment was discovered…

28 October 2020

REVIVE Webinar: Developing antibiotics for children – medical need and regulatory challenges

All webinars are recorded and can be viewed on revive.gardp.org/webinars

26 October 2020

BIO-Europe® 2020 Digital – 26th Annual International Partnering Conference

The 26th annual BIO-Europe® event is the largest biotechnology partnering conference held in Europe, though in 2020 by necessity we…

21 October 2020

REVIVE Webinar: Building better breakpoints: data and methods needed to determine breakpoints for new agents

In this webinar, John Turnidge and Anouk Muller will discuss how to determine breakpoints for new agents. The following topics…

page 1/8